That key 3000 level again. Joining us for the entire hour nancy tangler from tangler wealth management, welcome, nancy. Thank you, sara. We are seeing a nice rally on wall street. What are you doing right now what are you buying . Still focused on the consumer the china news is good but i dont expect us to get a deal soon u. S. Consumer. Yes, thank you. Although china did pretty well according to coke. Yeah, great interview by the way. Thank you mcdonalds, home depot, starbucks, those are some of the names we like in the consumer space as well as coke, one of our largest holdings. Who do you think likes the bachelor more i didnt know tyler was a fan. Im a super fan. Anyway lucky were getting that show on cnbc. Theyre one of the best couples. The new show. Oh, theyre from the bachelor. Im lost. Kayla tausche and seema mody has United Technologies and josh lipton has details on potential app de apple deal in the works and diana olick. Kayla, lets start with you. Wilf, theyre expected to
Kramer, well tell you how to experience a little bit of seinfeld in person. It is friday, june 28th, all day. Fbn a. M. Starts right now. Were going to have a party. Meet me at marys place. Were going to have a party. Ashley what a beautiful picture. Good morning, welcome to fbn a. M. Im as ashley webster, in for lauren simonetti. It is june 28th all day, its a friday. Cheryl end of the quarter, end of the month. Good morning, im cheryl casone. So lets take a look at how your money is moving this morning dow on pace for the best june since 1938, s p on track, best june since 1955. Green arrows s. Ashley investors keeping an eye on economic day a take today, lots of things for the market to consider. Were getting earnings from Constellation Brands before the bell. Cheryl stocks in asia, ahead of the big meeting between President Trump and xijinping, all red arrows across the board. Ashley in europe, theyre just getting their day underway, as opposed to asia, green arrows on the ftse, th
For the highlyanticipated rate cut. Tech sold out. The nasdaq hitting a record high before reversing lower as big tech is under fire the white house is hosting a summit targeting social media giants can tech rally in the face of the major headwinds or is the group handcuffed so many options as to where to go guy, what do you say first of all, this is unbelievable actually no. It was years ago it is interesting that, you know, billy joel, great artist and you played potentially his worst song. I knew you would say that. Thank you. Up town girl. Excellent point. Terrible song. With that said, can you still buy tech here . I think theres still an inch you can buy. Facebook, if thats technology, will rally in energy i think on microsoft, thats fine lets look at micron real quick because i think it is where the battle line is being drawn that stock was at 32 on june 25th when they reported earnings, and the stock has rallied probably 30 since then you sort of break down the earnings guess w
False sense of security. Youll hear it even if youre a sedate daytime today where the dow gained 69 points s p climbed to an alltime high, i should add getting bored by those, and the nasdaq advanced by 2. 2 . Heres my question what exactly are we too bullish about . Are there individual stocks, sectors, that have gone crazy . You know what, i always like to break things down. Lets take them one by one as opposed to making a sweeping judgment are we really being irrational with the banks, large sector in the market after last weeks run, tough to tell when you see major dividend and buyback boosts after, of course, the federal government review, they have good reason tore positive how can you feel the same way about the stock of Goldman Sachs when the company just increased by nearly 50 and rolled out a 7 billion buyback hey, thats more than 9 of the shares outstanding in the end, it got better off the crash test results and even here, i cant say theres that much enthusiasm these stocks
Toronto, Ontario (Newsfile Corp. - May 23, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is announcing that it has appointed David Posner to its Advisory Committee